Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

US Patent 11174248 · Granted Nov 16, 2021

Estimated economic value: $200,946,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipidated peptide inhibitors of interleukin-23 receptor2025
Method and system for vertical gradient freeze 8 inch gallium arsenide substrate2025
SHP2 phosphatase inhibitors and methods of use thereof2025
Germanium single-crystal wafer, method for preparing germanium single-crystal wa2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
Rollator2025
NK3 modulators and uses thereof2025
Low etch pit density gallium arsenide crystals with boron dopant2025